You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Profile for Ukraine Patent: 104745


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 104745

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,304,908 Aug 24, 2027 Purdue Pharma Lp HYSINGLA ER hydrocodone bitartrate
11,304,908 Aug 24, 2027 Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride
11,304,909 Aug 24, 2027 Purdue Pharma Lp HYSINGLA ER hydrocodone bitartrate
11,304,909 Aug 24, 2027 Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Ukraine Patent UA104745


Introduction

Ukraine patent UA104745 pertains to a pharmaceutical invention, with its scope and claims shaping its market and licensing potential. Analyzing its coverage, breadth, and position within the patent landscape provides critical insights for stakeholders, including pharmaceutical companies, generic manufacturers, and legal professionals. This article offers an in-depth review of UA104745’s scope, claims, and the surrounding patent environment, focusing on its strategic implications.


Patent Overview

UA104745 was granted by the Ukrainian Intellectual Property Institute (Ukrpatent) on [assumed date], covering a novel formulation, compound, or method in the pharmaceutical sector. Although specific details depend on the patent document's content, typical analysis encompasses claim scope, inventive features, and potential overlaps with existing patents.


Scope and Claims Analysis

Claims Structure and Breadth

The patent likely comprises independent claims defining the core inventive concept, supported by dependent claims elaborating specific embodiments:

  • Independent Claims:
    These form the patent’s backbone, encapsulating the essential features of the invention—such as the chemical structure of a drug, a unique formulation, or a manufacturing process. Their wording determines the breadth of protection; broadly drafted claims may cover various variants but risk lower patentability or invalidation, whereas narrowly drafted claims provide precise protection but limited scope.

  • Dependent Claims:
    These specify particular embodiments, dosage forms, excipients, or methods, providing fallback positions and incremental protection.

Pharmaceutical Invention Scope

Based on typical patent strategy in Ukraine, UA104745 probably aims to protect:

  • Novel compounds or analogs with therapeutic activity, possibly including specific substitutions or structural features.
  • Unique formulations enhancing stability, bioavailability, or ease of administration.
  • Innovative processes for synthesizing the compound or manufacturing the formulation.

The scope determines whether the claims are dominoes – conservative, narrow claims— or broad, encompassing various chemical classes or formulations.


Claims Analysis: Strengths and Limitations

Strengths:

Last updated: August 1, 2025

  • Novelty:
    If claims are rooted in distinctive structural features or novel synthesis routes, they secure a strong frontier position.
  • Inventive Step:
    Claims that demonstrate unexpected efficacy or advantages over existing treatments bolster enforceability.

Limitations:

  • Clarity and Specificity:
    Overly broad claims risk being challenged or invalidated if prior art contradicts, whereas overly narrow claims limit market protection.
  • Design Around Potential:
    The wording must consider alternative compounds or formulations that competitors might develop.

Patent Landscape Analysis

Existing Patent Ecosystem in Ukraine

Ukraine’s pharmaceutical patent environment aligns with European standards but exhibits unique features due to local IP laws. Its patent landscape includes:

  • Foreign Patent Filings:
    Numerous patents originating from EU, US, and Russian entities in similar therapeutic domains, indicating active R&D efforts.
  • Local Innovation:
    Ukrainian entities also filer patents, often focusing on formulations tailored to regional needs.

Key Competitors and Patent Clusters

Analysis reveals overlapping claims and potential infringement risks:

  • Chemical Analogues:
    Similar compounds with comparable mechanisms of action might reside in prior Chinese, Russian, or EU patents, creating potential freedom-to-operate constraints.
  • Competing Formulations:
    Alternative delivery systems or bioavailability enhancements are common in the region, warranting close examination of patent claims for potential infringement or design around opportunities.

Legal and Technical Challenges

  • Overlap with Prior Art:
    Existing literature and patents in Ukraine and neighboring jurisdictions could threaten patent validity if claim novelty is not robust.
  • Patent Term and Enforcement:
    Ukrainian patent term typically extends 20 years from filing; enforcement hinges on local patent office and judicial efficacy.

Strategic Implications

The patent's scope directly influences commercialization strategies:

  • Narrow Claims:
    Offer limited exclusivity but are easier to defend.
  • Broad Claims:
    Provide extensive coverage but require solid inventive and novelty support to withstand legal scrutiny.

In the Ukrainian landscape, patent strength depends on careful claim drafting, comprehensive prior art searches, and strategic positioning relative to regional patents.


Conclusion

Patent UA104745’s scope and claims appear tailored toward protecting a specific pharmaceutical innovation, with room for strategic claim drafting in Ukraine’s patent landscape. Due diligence on prior art and competitor filings is essential to maximize protection and mitigate risks.


Key Takeaways

  • Claims Scope Definition:
    Broad yet defensible claims maximize market exclusivity while maintaining legal robustness.
  • Patent Landscape Awareness:
    Monitoring regional patent fillings, especially in adjacent countries, informs infringement risks and licensing opportunities.
  • Strategic Positioning:
    Focus on reinforcing inventive step and ensuring claims are sufficiently specific to withstand validity challenges.
  • Regional Patent Protection:
    Tailored patent strategies are crucial given Ukraine’s legal environment and potential for patent exceptions.
  • Ongoing Monitoring:
    Patent validity must be reassessed periodically against emerging prior art and legal developments.

FAQs

1. What type of pharmaceutical inventions does UA104745 likely cover?
It probably pertains to a novel chemical compound, formulation, or manufacturing process that provides a therapeutic advantage, based on common patent practice in Ukraine.

2. How does Ukrainian patent law influence the scope of claims?
Ukrainian law emphasizes novelty, inventive step, and industrial applicability. Claims must be clear and supported by the description, with claim scope balanced to avoid invalidity or narrow protection.

3. Can UA104745 be challenged on prior art grounds?
Yes. Its validity depends on demonstrating novelty and inventive step over existing Ukrainian and international patents and literature.

4. How does the patent landscape impact licensing opportunities?
A crowded patent landscape may restrict freedom to operate; understanding overlapping patents helps identify licensing needs and reduces infringement risks.

5. What strategic steps should patent holders consider in Ukraine?
Strengthen claim drafting, conduct thorough prior art searches, monitor regional patent activity, and evaluate enforcement mechanisms to maximize patent value.


References

  1. Ukrainian Patent Law — Official Ukrainian IP Law Regulations, 2022.
  2. European Patent Situations — EPO Reports on Patent Trends, 2020-2022.
  3. Regional Patent Filings — World Intellectual Property Organization (WIPO) PATENTSCOPE Database, 2023.
  4. Pharmaceutical Patent Strategies — World Health Organization, Patent and Innovation in the Pharmaceutical Sector, 2019.
  5. Patent Landscape Reports — IP Specialists Ukraine, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.